jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacy PracticeNOW IN
Article

Optimal assessment share structured of Pharmacoeconomics for medical drugs according to minimax criterion

Roza Yagudina1, Alex Borodin2, Andrey Kulikov1, Marina Protsenko1, Vyacheslav Serpik1★, Irina Vigodchikova3, Anastasia Dubinina4★ Corresponding author

  1. 1Department of Organization of Medical Provision and Pharmacoeconomics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
  2. 2Department of Finance of Sustainable, Plekhanov Russian University of Economics, 117997 Moscow, Russia.
  3. 3National Research Saratov State University named after N. G. Chernyshevsky, Department of differential equations and mathematical Economics, Saratov, Russia.
  4. 4I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.

CORRESPONDENCE

Vyacheslav Serpik

Department of Organization of Medical Provision and Pharmacoeconomics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.

serpik_v_g@staff.sechenov.ru

Received: 20-06-2023; Accepted: 22-07-2023.

Volume 22, Issue 1 · pp. 2909 · PUBLISHED 2 January 2024 · DOI: 10.18549/PharmPract.2024.1.2909

View on PP original site ↗

ABSTRACT

Objective: To develop a comprehensive methodology for the optimal assessment of the share of the use of medicines, based on the procedure for ranking drugs according to the pharmacoeconomic point scale and the minimax criterion was applied. Methods: The author’s approach is based on the minimax principle and allows solving the problem of optimizing the pharma drug portfolio based on available data, without the need to obtain the parameters of the Markowitz model associated with correlation analysis of data. Results: The authors obtained the optimal distribution of medicines in group A, B: 37% to 63%, which the authors consider a promising recommendation for a pharmaceutical company. The use of a similar approach, which does not contradict the Markowitz methodology, but allows us to reasonably accept the parameters of the model and give the optimal solution for the share distribution of drugs in medical practice. Conclusion: These mathematical tools, justified and equipped with an alternative confirmation, the minimax task can and should take a significant place in the complex pharma-analytical methodology of the management of large companies supplying concomitant drugs to the Russian and foreign market.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Yagudina, R., Borodin, A., Kulikov, A., Protsenko, M., Serpik, V., Vigodchikova, I., & Dubinina, A. (2024). Optimal assessment share structured of Pharmacoeconomics for medical drugs according to minimax criterion. Pharmacy Practice, 22(1), 2909. https://doi.org/10.18549/PharmPract.2024.1.2909